Framework Agreement for In Vivo Studies on NB-PDX Models in Mice
Rahmenvertrag über In-Vivo-Studien an NB-PDX-Modellen in Mäusen
Germany · Berlin · how to bid here →
Your path to submission
- Deadline: 23 October at 10:00 — 20 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 3 months (27 awards, most recently May 2026) — by that rhythm the next award was due around August 2026. The last award went to Zentrum für Klinische Studien Leipzig.n = 27
- 4% of the bids received came from other countries (314 procedures with a bid mix) — all bidders, not just the winners. Sector: 26%.n = 314
- 50% of this buyer's awards went to companies that had already won here before (1,105 awards since 2017, spread over 548 companies). 50% went to new names.n = 1,105 awards since 2017
- The median procedure drew 2 bids (992 procedures with a bid count); 40% ended with a single bidder. Sector: median 1 bids.n = 992
- 88% of the bids received came from small and medium-sized enterprises (314 procedures with a bid mix). Sector: 73%.n = 314
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 27/09/2026.
Foreign bidders
In Germany · R&D services, 157 contracts went to foreign companies over the last 3 years (of 3,946 recorded awards) — mostly from Netherlands, Italy, Belgium.
Submission language: DEU.
Typical field: median 1 (from 27 awards).
What the buyer is looking for
The Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin is issuing a framework contract for the execution of in vivo studies (therapy, characterization or biodistribution/pharmacokinetics studies) on patient-derived neuroblastoma xenograft models in mice ("NB-PDX models") together with the extraction of PDX tumor material. This is a framework contract with only one contractor. There are separate requirements under the Berlin Tender and Procurement Act (BerlAVG), see procurement documents. Further information can be found in the documents provided on the Charité allocation platform (https://vergabeplattform.charite.de).
What you must prove — eligibility criteria
Gefordert sind zwei Unternehmensreferenzen aus den letzten 6 Jahren (2020 - 2025) über früher ausgeführte oder laufende vergleichbare Aufträge. Sofern es sich um Aufträge handelt, die in den letzten 6 Jahren noch nicht abgeschlossen wurden, ist der bisher erre… ▸▾
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Siemens Healthcare GmbH · Erlangen | 29 | 2018–2025 |
| SAP Deutschland SE & Co. KG · Walldorf | 20 | 2022–2025 |
| SVA System Vertrieb Alexander GmbH | 16 | 2019–2026 |
| Philips GmbH | 14 | 2019–2025 |
| ALBA Berlin GmbH · Berlin | 13 | 2014–2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.